Heart problems that develop during an intensive care stay in critically ill adults
Official title: Intensive Care Unit-acquired Heart Failure in Critically Ill: the ICU-HF Study
Run by Charite University, Berlin, Germany · NCT07094425 · Data updated 2026-11-12
This project uses bedside heart ultrasound and body composition measurements to see how often adults who need mechanical ventilation within 24 hours of ICU admission develop new heart dysfunction and muscle weakness.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | Charite University, Berlin, Germany Academic / other |
| Locations | 2 sites (Vienna, State of Vienna and 1 other locations) |
| Status | Recruiting |
| Started | August 7, 2025 |
| Main results expected | August 1, 2026 |
| Study ends | November 1, 2026 |
| Registry record updated | August 13, 2025 |
| Trial ID | NCT07094425 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥18 years) admitted to participating ICUs who require mechanical ventilation within 24 hours of admission and are expected to stay in the ICU at least three days are ideal candidates.
✕Probably not a fit
Patients who are expected to die during the ICU stay, are transitioning to comfort-only care, have contraindications to the measurements (e.g., pacemaker, severe aortic stenosis, skin conditions preventing ultrasound), or for whom ultrasound is not technically feasible are unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study enrolls critically ill adults who start mechanical ventilation within 24 hours of ICU admission and are expected to remain in the ICU for at least three days. Participants receive transthoracic echocardiography and body-muscle assessments during their ICU stay to document cardiac function and muscle mass/strength. The goal is to describe how often and when heart dysfunction and Intensive Care Unit–acquired weakness occur, and how these problems relate to each other and to short-term outcomes. The work is conducted at Charité – Universitätsmedizin Berlin and the Medical University of Vienna and does not test an experimental treatment.
Why it matters
Potential benefit: If successful, the findings could help clinicians recognize ICU-related heart dysfunction earlier and guide monitoring or supportive care to reduce long-term disability and mortality.
How similar studies have gone: Previous research has documented ICU-acquired muscle wasting and separate reports have noted cardiac dysfunction after critical illness, but systematically pairing serial bedside echocardiography with muscle assessments to define ICU-acquired heart failure is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Critically ill patients aged ≥ 18 years * Initiation of mechanical ventilation within the first 24 hours after ICU admission * Expected duration of ICU stay of at least 3 days Exclusion Criteria: * Language barriers * Expected death during ICU stay or planned transition to best supportive care * Known allergy to electrode gel * Ultrasound not technically feasible (e.g., due to extensive wounds, skin rash, or dressings) * Patients with a pacemaker or similar electronic devices for whom bioelectrical impedance analysis (BIA) is contraindicated * Patients with severe aortic valve stenosis
Where it's running
-
Medical University of Vienna
Vienna, State of Vienna, Austria Recruiting -
Charité - Universitätsmedizin Berlin
Berlin, State of Berlin, Germany Recruiting
Study contacts
- Principal investigator: Stefan J Schaller, MD — Charite University, Berlin, Germany
- Study coordinator: Stefan J Schaller, MD
- Email: stefan.schaller@charite.de
- Phone: +49 30 450 631289
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using Apple Watch data to predict heart failure outcomes
This study is testing if data from Apple Watches can help predict heart failure problems and the chances of needing to go back to the hospital for patients with heart failure.
-
Comparing Aortix Device to Diuretics for Acute Heart Failure
This study is testing whether the Aortix device can help people with acute heart failure who aren't responding to diuretics feel better compared to standard treatment.
-
Myocardial Energetics Across Cardiovascular Disease Spectrum Using 31P-MRS
Researchers are testing whether phosphorus-31 magnetic resonance spectroscopy (31P-MRS) can map heart energy metabolism across healthy people and patients with various heart conditions.
-
Tailored digital support to cut sedentary time in long-term cardiac rehab
In adults in a long-term cardiac rehabilitation program, this study tests whether a personalized behavioural program with digital tools can reduce daily sitting time.
-
NT-proBNP–guided heart failure screening for people 65+ in rural China
This study tests whether using NT-proBNP blood tests to guide heart failure screening in adults 65 and older in rural China can find unrecognized heart problems more effectively than symptom-based screening.
-
Voice-based detection of heart failure deterioration using Noah Labs Vox
This study tests whether a voice-analysis app can flag worsening heart failure in adults by comparing its alerts to standard weight-based monitoring.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.